|
1例晚期胃癌患者的循证治疗
|
Abstract:
[1] | Acín-Gándara, D., Pereira-Pérez, F., Casta?o-Pascual, A., et al. (2012) Gastrointestinal stromal tumors: Diagnosis and treatment. Cirugía y Cirujanos, 80, 44-51. |
[2] | Nagasako, Y., Satoh, S., Isogaki, J., et al. (2012) Impact of anastomotic complications on outcome after laparoscopic gastrectomy for early gastric cancer. British Journal of Surgery, 99, 849-854. http://dx.doi.org/10.1002/bjs.8730 |
[3] | Lorenzen, S., Blank, S., Lordick, F., et al. (2012) Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients. Annals of Surgical Oncology, 19, 2119-2127. http://dx.doi.org/10.1245/s10434-012-2254-1 |
[4] | Bornschein, J., Rokkas, T., Selgrad, M., et al. (2011) Gastric cancer: Clinical aspects, epidemiology and molecular background. Helicobacter, 16, 45-52. http://dx.doi.org/10.1111/j.1523-5378.2011.00880.x |
[5] | Blank, S., Bl?ker, H., Schaible, A., et al. (2012) Impact of pretherapeutic routine clinical staging for the individualization of treatment in gastric cancer patients. Langenbeck’s Archives of Surgery, 397, 45-55.
http://dx.doi.org/10.1007/s00423-011-0805-8 |
[6] | Becker, K., Langer, R., Reim, D., et al. (2011) Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: A summary of 480 cases. Annals of Surgery, 253, 934-939.
http://dx.doi.org/10.1097/SLA.0b013e318216f449 |
[7] | 王瑾, 曲秀娟, 滕月娥, 等 (2013) 卡培他滨联合多西紫杉醇一线治疗晚期的临床观察. 临床肿瘤学杂志, 5, 442-444. |
[8] | Miyazaki, S., Kimura, Y., Danno, K., et al. (2011) S 1 treatment for elderly patients over 75 years with gastric cancer. Gan To Kagaku Ryoho, 38, 581-584. |
[9] | Nio, Y., Koike, M., Omori, H., et al. (2004) A randomized consent design trial of neoadjuvant chemotherapy with tegafurplusuracil (UFT) for gastric cancer—A single institute study. Anticancer Research, 24, 1879-1887. |
[10] | 董平, 顾钧, 陆建华, 等 (2009) 进展期胃癌新辅助化疗的临床研究. 浙江临床医学, 8, 807-808. |
[11] | Cunningham, D., Allum, W.H., Stenning, S.P., et al. (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. The New England Journal of Medicine, 355, 11-20.
http://dx.doi.org/10.1056/NEJMoa055531 |
[12] | Boige, V., Pignon, J., Saint-Aubert, B., et al. (2007) Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE). American Society of Clinical Oncology, 25, 4510. |
[13] | Opitz, I., Kestenholz, P., Lardinois, D., et al. (2006) Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. European Journal Cardio-Thoracic Surgery, 29, 579-584. http://dx.doi.org/10.1016/j.ejcts.2006.01.015 |
[14] | Earle, C.C., Maroun, J. and Zuraw, L. (2002) Cancer Care Ontario Practice Guidelines Initiative Gastrointestinal Cancer Disease Site Group. Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline. Canadian Journal of Surgery, 45, 438-446. |
[15] | Stein, H.J., Feith, M. and Siewert, J.R. (2000) Cancer of the esophagogastric junction. Surgical Oncology, 9, 35-41.
http://dx.doi.org/10.1016/S0960-7404(00)00021-9 |